Mayur Ian Somaiya

Mayur Ian Somaiya

50 ans
Finance
Health Technology
Consumer Services

Profil

Mayur Ian Somaiya is currently the Chief Financial Officer at NewAmsterdam Pharma Co. NV since 2023.
He previously held managing director and senior research analyst positions at Piper Sandler & Co. (Broker) from 2010 to 2013, managing director positions at Thomas Weisel Partners LLC from 2003 to 2009, managing director and senior analyst positions at Nomura Securities International, Inc. from 2013 to 2016, managing director and analyst positions at BMO Capital Markets Corp.
(Broker) from 2016 to 2018, and was the Chief Financial Officer at TCR2 Therapeutics, Inc. from 2018 to 2021.
He also worked as an analyst at Prudential Securities from 1997 to 1999 and as a senior analyst at Morgan Stanley & Co. LLC from 2000 to 2002.
Additionally, he worked as a consultant at Carson Group, Inc. (New York) in 1996.
Mr. Somaiya received his undergraduate degree from New York University in 1995.

Postes actifs de Mayur Ian Somaiya

Anciens postes connus de Mayur Ian Somaiya

SociétésPosteFin
TCR2 THERAPEUTICS INC. Director of Finance/CFO 10/12/2021
Analyst-Equity 01/04/2018
Analyst-Equity 01/01/2016
Analyst-Equity 31/10/2013
Analyst-Equity 15/10/2009
Voir l'expérience en détail de Mayur Ian Somaiya

Formation de Mayur Ian Somaiya

New York University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mayur Ian Somaiya

Relations

100 +

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
FRAZIER LIFESCIENCES ACQUISITION CORPORATION

Health Technology

Entreprise privées8
Prudential Securities

Finance

Finance

Finance

Finance

Finance

Finance

Finance

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Mayur Ian Somaiya